Hypercoagulable states: A review

Vascular and Endovascular Surgery

Volumn 39, Issue 2, 2005, Pages 123-133

  Johnson, Colleen M ^a   Mureebe, Leila ^b,c   Silver, Donald ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b Columbia Univ Coll of Phys/Surgs ^*  (United States)

^c Division of Vascular Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; BLOOD CLOTTING FACTOR 5 LEIDEN; DICOUMAROL; ENOXAPARIN; ESTROGEN; HEPARIN; HEPARIN COFACTOR II; HIRUDIN; HOMOCYSTEINE; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; PROSTACYCLIN; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN;

ARTERY THROMBOSIS; DIFFERENTIATION; GENE MUTATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; PREGNANCY; PROTEIN DEFICIENCY; RECURRENT ABORTION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SKIN NECROSIS; SMOKING; SPONTANEOUS ABORTION; TERATOGENICITY; THROMBOEMBOLISM; VASCULAR SURGERY; VEIN THROMBOSIS;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; NECROSIS; PREGNANCY; SKIN; SMOKING; THROMBOCYTOPENIA; THROMBOPHILIA;

EID: 16844363626     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440503900201     Document Type: Review

References (58)

1. American Lung Association: Trends in Tobacco Use. www.lungusa.org (June 2003).
2. Myers KA, King RB, Scott DF, et al: The effects of smoking on the late patency of arterial reconstruction in the legs. Br J Surg 65:267-271, 1978.
3. Newby DE, Wright RA, Labinjoh C, et al: Endothelial dysfunction, impaired fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction. Circulation 99:1411-1415, 1999.
4. Barua RS, Ambrose JA, Saha DC, et al: Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: An in vitro demonstration. Circulation 106:905-908, 2002.
5. Matezky S, Tani S, Kangavari S, et al: Smoking increases tissue factor expression in atherosclerotic plaques: Implications for plaque thrombogenicity. Circulation 102:602-604, 2000.
6. Murray D, Jaques L, Perrett T, et al: Heparin and the thrombosis of veins following injury. Surgery 2:163-187, 1937.
7. Adams JG Jr, Humphrey LJ, Zhang X, et al: Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies? J Vasc Surg 21:247-253, 1995.
8. Almeida JL, Coats R, Liem TK, et al: Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. J Vasc Surg 27:309-314, 1998.
9. Kite MJ, Keller MP, Humphrey PW, et al: Can low molecular weight heparins and heparinoids be safely given to patients with heparin induced- thrombocytopenia syndrome? Surgery 114:705-710, 1993.
10. Flood EP, Redish MH, Bociek SJ, et al: Thrombophlebitis migrans disseminate: Report of a case in which gangrene of the breast occurred. Observations on therapeutic use of dicumarol (3,3′methylene bis(4-hydroxycoumarin)). NY State J Med 43:1121-1124, 1943.
11. Cole MS, Minifee PK, Wolma FJ: Coumarin necrosis-a review of the literature. Surgery 103:271-277, 1988.
12. Norris PG: Warfarin skin necrosis treated with prostacyclin. Clin Exp Dermatol 12:370-372, 1987.
13. Wasserman A, Neisser A, Bruck C: Eine serodianostiche Reaktion bei Syphilis. Deutsche Med Wochenschr 32:745-746, 1906.
14. Wilson WA, Ghavari AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42: 1309-1311, 1999.
15. Petri M: Epidemiology of the antiphospholipid syndrome. J Autoimmun 15:145-151, 2000.
16. Cervera R, Khamashta MA, Font J, et al: Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 72:113-124, 1993.
17. Dilley A, Austin H, El-Jamil M, et al: Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 183:1271-1277, 2000.
18. Bombeli T, Raddatz-Mueller P, Fehr J: Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women. Am J Obstet Gynecol 184:382-389, 2001.
19. Danilenko-Dixon DR, Heit JA, Silverstein MD, et al: Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or postpartum: A population-based, case-control study. Am J Obstet Gynecol 184:104-110, 2001.
20. Carter C: Oral contraceptives and thrombosis. Curr Opin Pulm Med 6:296-300, 2000.
21. Quehenberger P, Loner U, Kapiotis S, et al: Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb Haeomost 76:729-734, 1996.
22. Vandenbrouke JP, Koster T, Briet E, et al: Increased risk of venous thrombosis in oral contraceptive users who are carrier of factor V Leiden mutation. Lancet 344:1453-1457, 1994.
23. Key NS, Ely EW: Coagulation inhibition for sepsis. Curr Opin Hematol 9:416-421, 2002.
24. Trousseau A: Phlegmasia alba dolens: Clinique medicale de l'Hotel-Dieu de Paris, ed. 2. Paris, France: J. B. Alliere et Fils, 1865, pp 654-712.
25. Silverstein MD, Heit JA, Mohr DN, et al: Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 158:585-593, 1998.
26. Lane DA, Mannucci PM, Bauer KA, et al: Inherited thrombophilia: Part I. Thromb Haemost 76:651-662, 1996.
27. Egeberg O: Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 13:516-530, 1965.
28. Sagar S, Nairn D, Stamatakis JD, et al: Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet 1:1151-1154, 1976.
29. Seligsohn U, Lubetsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 344:1222-1231, 2001.
30. Bucciarelli P, Rosendaal F, Tripodi A, et al: Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: A multicenter collaborative family study. Arterioscler Thromb Vasc Biol 19:1026-1033, 1999.
31. Pabinger I, Schneider B: Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency: A co-operative, retrospective study. Arterioscler Thromb Vasc Biol 16:742-748, 1996.
32. Kearon C, Crowther M, Hirsch J: Management of patients with hereditary hypercoagulable disorders. Annu Rev Med 51:169-185, 2000.
33. Spronk HMH, Govers-Riemslag JWP, and ten Gate H: The blood coagulation system as a molecular machine. BioEssays 25:1220-1228, 2003.
34. Clouse LH, Comp PC: The regulation of hemostasis: The protein C system. N Engl J Med 314:1298-1304, 1986.
35. Folsom AR, Aleksic N, Wang L, et al: Protein C, antithrombin, and venous thromboembolism incidence: A prospective population-based study. Arterioscler Thromb Vasc Biol 22:1018-1022, 2002.
36. van Wijnen M, Stam J, van't Veer C, et al: The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 76:397-403, 1996.
37. Koppelman S, Hackeng T, Sixma J, et al: Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VI 11. Blood 86:1062-1071, 1995.
38. Gomez E, Ledford M, Pegelow C, et al: Homozygoius protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 71:723-726, 1994.
39. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, et al: A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med 126:1349-1366, 2002.
40. Bertina RM, Koeleman BP, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-66, 1994.
41. Ridker PM, Hennekens CH, Miledch JP: G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke and venous thrombosis in a large cohort of US men. Circulation 99:999-1004, 1999.
42. Poort SR, Rosendaal FR, Retisma PH, et al: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
43. Adrian N: Prothrombin G20210A polymorphism and thrombophilia. Mayo Clin Proc 75:595-604, 2000.
44. Doggen CJ, Cats VM, Bertina RM, et al: Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 2021 OA. Circulation 97:1037-1041, 1998.
45. de Jong S: Hyperhomocysteinaemia in patients with peripheral arterial occlusive disease. Clin Chem Lab Med 39:714-716, 2001
46. Hoogeveen EK, Kostense PJ, Jakobs C, et al: Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study. J Intern Med 247:442-448, 2000.
47. Valentine RJ, Kaplan HS, Green R, et al: Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis. J Vasc Surg 23:53-61; discussion 61-63, 1996.
48. Tripodi A, Mannucci PM: Laboratory investigation of thrombophilia. Clin Chem 47:1597-1606, 2001.
49. Schafer AI, Kroll MH: Nonatheromatous arterial thrombosis. Annu Rev Med 44:155-170, 1993.
50. Anonymous: Polycythemia vera: The natural history of 1,213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med 123:656-664, 1995.
51. Rao AK, Sheth S, Kaplan R: Inherited hypercoagulable states. Vasc Med 2:313-320, 1997.
52. Ray SA, Rowley MR, Loh A, et al: Hypercoagulable states in patients with leg ischemia. Br J Surg 81: 811-814, 1994.
53. Donaldson MC, Weinberg DS, Belkin M, et al: Screening for hypercoagulable states in vascular surgical practice: A preliminary study. J Vasc Surg 11:825-831, 1990.
54. Eldrup-Jorgensen J, Flanigan DP, Brace L, et al: Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 9:334-341, 1989.
55. Levy PJ, Hornung CA, Haynes JL, et al: Lower extremity ischemia in adults younger than forty years of age: A community-wide survey of premature atherosclerotic arterial disease. J Vasc Surg 19:873-881, 1994.
56. Levy PJ, Gonzalez FM, Rush DS, et al: Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis. J Am Coll Surg 178: 266-270, 1994.
57. Hughes GRV, Khamashta MA: The antiphospholipid syndrome. J Royal Coll Physicians London 28:301-304, 1994.
58. Tripodi A, Mannucci PM: Laboratory investigation of thrombophilia. Clin Chem 47:1957-1606, 2001.